NSAIDs vs placebo or active control: Improved contrast sensitivity
It is very uncertain whether NSAID changes improved contrast sensitivity  compared with placebo or active control (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
NSAID vs placebo or active control Improved contrast sensitivity  · participants with acute CME (< 4 months) following cataract surgery It is very uncertain whether NSAID changes improved contrast sensitivity  compared with placebo or active control (very low certainty). Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery (2022) · Cochrane Headline outcomes only | RR 1.11 [0.45, 2.75] | 1 study · 17 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.